A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
Status:
Completed
Trial end date:
2015-01-12
Target enrollment:
Participant gender:
Summary
This is a study to compare the efficacy of oral posaconazole to placebo for the treatment of
asymptomatic Chagas disease. The primary hypothesis of the study is that posaconazole 400 mg
twice daily improves therapeutic response compared to placebo in participants with a
diagnosis of asymptomatic chronic Chagas disease.